null

BCMA Biosimilar Antibody (HDBS0016)

SKU:
HDBS0016
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Protein:
BCMA
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€399

Description

system_update_altDatasheet

Anti-BCMA Biosimilar Antibody (HDBS0016)

The Anti-BCMA Monoclonal Antibody (HDbs0016) is a cutting-edge tool developed for researchers working in the field of immunotherapy and oncology. BCMA, or B-cell maturation antigen, is a cell surface receptor that is highly expressed in multiple myeloma and other B-cell malignancies. This monoclonal antibody, derived from hybridoma technology, specifically targets the BCMA protein, allowing for precise detection and analysis in experimental settings.Validated for use in various applications, including flow cytometry and immunohistochemistry, the Anti-BCMA Monoclonal Antibody (HDbs0016) is a versatile and reliable reagent for studying BCMA expression in both normal and diseased cells.

Its high specificity and sensitivity make it an invaluable tool for investigating the role of BCMA in cancer progression and identifying potential therapeutic targets for novel treatment strategies.With the increasing interest in targeting BCMA for immunotherapy in cancer patients, the Anti-BCMA Monoclonal Antibody (HDbs0016) offers researchers a powerful tool to advance their understanding of BCMA biology and develop innovative approaches for treating BCMA-positive malignancies. Don't miss out on this essential reagent for your research endeavors in the exciting field of cancer immunotherapy.